| P50 | author | Cornelis A. M. de Haan | Q88318820 |
| | Elisabeth A van Erp | Q88734341 |
| | Teun Guichelaar | Q88734343 |
| | Puck B van Kasteren | Q56450149 |
| P2093 | author name string | Gerben Ferwerda | |
| | Willem Luytjes | |
| | Oliver Wicht | |
| | Inge M L Ahout | |
| P2860 | cites work | Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease | Q26775152 |
| | Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody | Q27485050 |
| | Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored | Q27489549 |
| | Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006 | Q27491001 |
| | Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries | Q28069415 |
| | Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants | Q29620637 |
| | First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies | Q31156754 |
| | Risk of primary infection and reinfection with respiratory syncytial virus | Q34188122 |
| | Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease | Q34330690 |
| | The burden of respiratory syncytial virus infection in young children | Q34938343 |
| | Maternal antibody and viral factors in the pathogenesis of dengue virus in infants | Q35097469 |
| | Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh | Q35102554 |
| | RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets | Q35174945 |
| | Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern | Q35859950 |
| | Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya | Q36194104 |
| | Fcγ-receptor IIa-mediated Src Signaling Pathway Is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection | Q36236428 |
| | Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age | Q36263882 |
| | A role for immune complexes in enhanced respiratory syncytial virus disease | Q36371267 |
| | An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting | Q36444590 |
| | Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus | Q36473082 |
| | Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells | Q36687435 |
| | Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus | Q36858777 |
| | Epithelial cell lines of the cotton rat (Sigmodon hispidus) are highly susceptible in vitro models to zoonotic Bunya-, Rhabdo-, and Flaviviruses | Q36866624 |
| | Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV | Q37002523 |
| | Mechanisms of immunity to respiratory syncytial virus in cotton rats | Q37103582 |
| | Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine | Q37208256 |
| | Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis | Q37287212 |
| | Role of antibodies in controlling dengue virus infection | Q37406417 |
| | Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity | Q38162418 |
| | Fc receptors in antibody-dependent enhancement of viral infections | Q38615396 |
| | Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection | Q38989101 |
| | A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats | Q39696619 |
| | Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies. | Q39810460 |
| | Immune enhancement of viral infection | Q40132021 |
| | The American cotton rat: a novel model for pulmonary tuberculosis | Q40288350 |
| | Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity | Q40321692 |
| | Respiratory Syncytial Virus (RSV) Infects CD4+ T Cells: Frequency of Circulating CD4+ RSV+ T Cells as a Marker of Disease Severity in Young Children | Q40332252 |
| | RSV neutralization by palivizumab, but not by monoclonal antibodies targeting other epitopes, is augmented by Fc gamma receptors. | Q40672292 |
| | Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. | Q40673105 |
| | Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells | Q40959795 |
| | The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. | Q41682581 |
| | Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice | Q41843303 |
| | Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. | Q44076378 |
| | Respiratory pathogens in respiratory tract illnesses during the first year of life: a birth cohort study | Q44388107 |
| | Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children. | Q45364177 |
| | Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze | Q45387793 |
| | The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease | Q45397091 |
| | Lower respiratory tract infection caused by respiratory syncytial virus in infants: the role played by specific antibodies. | Q45397643 |
| | Antibody‐Dependent Enhancement, a Possible Mechanism in Augmented Pulmonary Disease of Respiratory Syncytial Virus in the Bonnet Monkey Model | Q45726252 |
| | Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine | Q45734744 |
| | Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). | Q45746077 |
| | Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population | Q45823296 |
| | Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. | Q45842807 |
| | Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. | Q52443988 |
| | IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assays | Q72575129 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-10-13 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants | |
| P478 | volume | 91 | |